TRIM21-mediated degradation of antibody-targeted cytosolic proteins
Ended Project Grant Awarded Last action
- Award ID
- R43CA250809
- Recipient
-
Alphathera, Inc. UEI NS86KWYJH4K3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $270,880
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $270,880 |
Quick answers
Who received award R43CA250809?
R43CA250809 was awarded to Alphathera, Inc. by National Cancer Institute (National Institutes of Health) on March 4, 2020.
How much is award R43CA250809 worth?
$270,880 has been obligated on R43CA250809.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award